-Female Pharmaceutical Pirate - Military Robot - Autonomous -

11:00 AM

Autonomous features a rakish female pharmaceutical pirate named Jack who traverses the world in her own submarine. A notorious anti-patent scientist who has styled herself as a Robin Hood heroine fighting to bring cheap drugs to the poor, Jack’s latest drug is leaving a trail of lethal overdoses across what used to be North America—a drug that compels people to become addicted to their work.

On Jack’s trail are an unlikely pair: an emotionally shut-down military agent and his partner, Paladin, a young military robot, who fall in love against all expectations. Autonomous alternates between the activities of Jack and her co-conspirators, and Joe and Paladin, as they all race to stop a bizarre drug epidemic that is tearing apart lives, causing trains to crash, and flooding New York City.

AMAZON | BARNES & NOBLE | BOOK DEPOSITORY

Praise for AUTONOMOUS

"Autonomous is to biotech and AI what Neuromancer was to the Internet."―Neal Stephenson

"Something genuinely and thrillingly new in the naturalistic, subjective, paradoxically humanistic but non-anthropomorphic depiction of bot-POV―and all in the service of vivid, solid storytelling."―William Gibson

"This book is a cyborg. Partly, it's a novel of ideas, about property, the very concept of it, and how our laws and systems about property shape class structure and society, as well as notions of identity, the self, bodies, autonomy at the most fundamental levels, all woven seamlessly into a dense mesh of impressive complexity. Don't let that fool you though. Because wrapped around that is the most badass exoskeleton--a thrilling and sexy story about pirates and their adventures. Newitz has fused these two layers together at the micro- and macro-levels with insight and wit and verbal flair. Moves fast, with frightening intelligence." ―Charles Yu, author of How to Live Sagfely in a Science Fictional Universe

"Annalee Newitz has conjured the rarest, most exciting thing: a future that's truly new ... a terrific novel and a tremendous vision." ―Robin Sloan, author of Mr. Penumbra's 24-Hour Bookstore

"Holy hell. Autnomous is remarkable." ―Lauren Beukes, bestselling author of Broken Monsters

"Everything you'd hope for from the co-founder of io9 ... Combines the gonzo, corporatized future of Neal Stephenson's Snow Crash with the weird sex of Charlie Stross's Saturn's Children; throws in an action hero that's a biohacker version of Bruce Sterling's Leggy Starlitz, and then saturates it with decades of deep involvement with free software hackers, pop culture, and the leading edge of human sexuality." ―Cory Doctorow, New York Times bestselling author of Walkaway.

EXCERPT

The sub’s cargo hold was currently stacked with twenty crates of freshly pirated drugs. Tucked among the many therapies for genetic mutations and bacterial management were boxes of cloned Zacuity, the new blockbuster productivity pill that everybody wanted. It wasn’t technically on the market yet, so that drove up demand. Plus, it was made by Zaxy, the company behind Smartifex, Brillicent, and other popular work enhancement drugs. Jack had gotten a beta sample from an engineer at Vancouver’s biggest development company, Quick Build Wares. Like a lot of biotech corps, Quick Build handed out new attention enhancers for free along with their in-house employee meals. The prerelease ads said that Zacuity helped everyone get their jobs done faster and better.

Jack hadn’t bothered to try any Zacuity herself—she didn’t need drugs to make her job exciting. The engineer who’d provided the sample described its effects in almost religious terms. You slipped the drug under your tongue, and work started to feel good. It didn’t just boost your concentration. It made you enjoy work. You couldn’t wait to get back to the keyboard, the breadboard, the gesture table, the lab, the fabber. After taking Zacuity, work gave you a kind of visceral satisfaction that nothing else could. Which was perfect for a corp like Quick Build, where new products had tight ship dates, and consultants sometimes had to hack a piece of hardware top-to-bottom in a week. Under Zacuity’s influence, you got the feelings you were supposed to have after a job well done. There were no regrets, nor fears that maybe you weren’t making the world a better place by fabricating another networked blob of atoms. Completion reward was so intense that it made you writhe right in your plush desk chair, clutching the foam desktop, breathing hard for a minute or so. But it wasn’t like an orgasm, not really. Maybe it was best described as physical sensation, perfected. You could feel it in your body, but it was more blindingly good than anything your nerve endings might read as inputs from the object-world. After a Zacuity-fueled work run, all you wanted to do was finish another project for Quick Build. It was easy to see why the shit sold like crazy.

But there was one little problem, which she’d been ignoring until now. Zaxy didn’t make data from their clinical trials available, so there was no way to find out about possible side effects. Normally Jack wouldn’t worry about every drug freak-out reported on the feeds, but this one was so specific. She couldn’t think of any other popular substances that would get someone addicted to homework. Sure, the student’s obsessive behavior could be set off by a garden-variety stimulant. But then it would hardly be a medical mystery, since doctors would immediately find evidence of the stimulant in her system. Jack’s mind churned as if she’d ingested a particularly nasty neurotoxin. If this drug was her pirated Zacuity, how had this happened? Overdose? Maybe the student had mixed it with another drug? Or Jack had screwed up the reverse engineering and created something horrific?

Jack felt a twitch of fear working its way up her legs from the base of her spine. But wait—this shiver wasn’t just some involuntary, psychosomatic reaction to the feeds. The floor was vibrating slightly, though she hadn’t yet started the engines. Ripping off the goggles, she regained control of her sensorium and realized that somebody was banging around in the hold, directly behind the bulkhead in front of her. What the actual fuck? There was an aft hatch for emergencies, but how—? No time to ponder whether she’d forgotten to lock the doors. With a predatory tilt of the head, Jack powered up her perimeter system, its taut nanoscale wires networked with sensory nerves just below the surface of her skin. Then she unsnapped the sheath on her knife. From the sound of things, it was just one person, no doubt trying to grab whatever would fit in a backpack. Only an addict or someone truly desperate would be that stupid.

She opened the door to the hold soundlessly, sliding into the space with knife drawn. But the scene that met her was not what she expected. Instead of one pathetic thief, she found two: a guy with the scaly skin and patchy hair of a fusehead, and his robot, who was holding a sack of drugs. The bot was some awful, hacked-together thing the thief must have ripped off from somebody else, its skin layer practically fried off in places, but it was still a danger. There was no time to consider a nonlethal option. With a practiced overhand, Jack threw the knife directly at the man’s throat. Aided by an algorithm for recognizing body parts, the blade passed through his trachea and buried itself in his artery. The fusehead collapsed, gagging on steel, his body gushing blood and air and shit.

In one quick motion, Jack yanked out her knife and turned to the bot. It stared at her, mouth open, as if it were running something seriously buggy. Which it probably was. That would be good for Jack, because it might not care who gave it orders as long as they were clear.

“Give me the bag,” she said experimentally, holding her hand out. The sack bulged with tiny boxes of her drugs. The bot handed it over instantly, mouth still gaping. He’d been built to look like a boy in his teens, though he might be a lot older. Or a lot younger.

At least she wouldn’t have to kill two beings today. And she might get a good bot out of the deal, if her botadmin pal in Vancouver pitched in a little. On second glance, this one’s skin layer didn’t look so bad, after all. She couldn’t see any components peeking through, though he was scuffed and bloody in places.

“Sit down,” she told him, and he sat down directly on the floor of the hold, his legs folding like electromagnetically joined girders that had suddenly lost their charge. The bot looked at her, eyes vacant. Jack would deal with him later. Right now, she needed to do something with his master’s body, still oozing blood onto the floor. She hooked her hands under the fusehead’s armpits and pulled his remains through the bulkhead door into the control room, leaving the bot behind her in the locked hold. There wasn’t much the bot could do in there by himself, anyway, given that all her drugs were designed for humans.

Down a tightly coiled spiral staircase was her wet lab, which doubled as a kitchen. A high-grade printer dominated one corner of the floor, with three enclosed bays for working with different materials: metals, tissues, foams. Using a smaller version of the projection display she had in the control room, Jack set the foam heads to extrude two cement blocks, neatly fitted with holes so she could tie them to the dead fusehead’s feet as easily as possible. As her adrenaline levels came down, she watched the heads race across the printer bed, building layer after layer of matte-gray rock. She rinsed her knife in the sink and resheathed it before realizing she was covered in blood. Even her face was sticky with it. She filled the sink with water and rooted around in the cabinets for a rag.

Loosening the molecular bonds on her coveralls with a shrug, Jack felt the fabric split along invisible seams to puddle around her feet. Beneath plain gray thermals, her body was roughly the same shape it had been for two decades. Her cropped black hair showed only a few threads of white. One of Jack’s top sellers was a molecule-for-molecule reproduction of the longevity drug Vive, and she always quality-tested her own work. That is, she hadalways quality tested it—until Zacuity. Scrubbing her face, Jack tried to juggle the two horrors at once: A man was dead upstairs, and a student in Calgary was in serious danger from something that sounded a lot like black-market Zacuity. She dripped on the countertop and watched the cement blocks growing around their central holes.

Jack had to admit she’d gotten sloppy. When she reverse engineered the Zacuity, its molecular structure was almost exactly like what she’d seen in dozens of other productivity and alertness drugs, so she hadn’t bothered to investigate further. Obviously she knew Zacuity might have some slightly undesirable side effects. But these fun-time worker drugs subsidized her real work on antivirals and gene therapies, drugs that saved lives. She needed the quick cash from Zacuity sales so she could keep handing out freebies of the other drugs to people who desperately needed them. It was summer, and a new plague was wafting across the Pacific from the Asian Union. There was no time to waste. People with no credits would be dying soon, and the pharma companies didn’t give a shit. That’s why Jack had rushed to sell those thousands of doses of untested Zacuity all across the Free Trade Zone. Now she was flush with good meds, but that hardly mattered. If she’d caused that student’s drug meltdown, Jack had screwed up on every possible level, from science to ethics.

With a beep, the printer opened its door to reveal two perforated concrete bricks. Jack lugged them back upstairs, wondering the entire time why she had decided to carry so much weight in her bare hands.

Copyright © 2017 by Annalee Newitz

ABOUT THE AUTHOR

Annalee Newitz is an American journalist, editor, and author of both fiction and nonfiction. She is the recipient of a Knight Science Journalism Fellowship from MIT, and has written for Popular Science, Wired, and the San Francisco Bay Guardian. She also founded the science fiction website io9 and served as Editor-in-Chief from 2008–2015, and subsequently edited Gizmodo. As of 2016, she is Tech Culture Editor at the technology site Ars Technica. Her books include Pretend We're Dead and Autonomous.